The 2015 STD Treatment Guidelines released by the Centers for Disease Control and Prevention (CDC) in June 2015, include several major updates to the section on trichomoniasis.1
The new guidelines were developed based on a thorough review of current scientific evidence, said Elissa Meites, MD, MPH, a medical epidemiologist at the CDC, who led development of the section.
She added, however, that an examination of available literature supports the notion that trichomoniasis is a “neglected” infection about which many important questions remain unanswered.
Dr Meites is lead author of the published paper that reviews scientific evidence used for the development of the 2015 STD Treatment Guidelines section on trichomoniasis.2 She also wrote and coauthored other articles reviewing and discussing trichomoniasis as a neglected infection.3,4
As noted in the latter paper, research and control efforts for Trichomonas vaginalis infection traditionally have lagged far behind efforts for other sexually transmitted infections (STIs), even though T. vaginalis infection is the most prevalent non-viral STI in the United States and more common than chlamydia, gonorrhea, and syphilis infections combined.
The authors concluded, “Increased emphasis on detection and treatment of infections is needed to move trichomoniasis out of the neglected category and to provide better care for those most impacted by this parasitic disease.”4
As noted in the published paper, poor understanding of its public health impact is one important factor in the low level of attention given to T. vaginalis infection.